Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Austria (1)
Belgium (3)
Brazil (1)
Cambodia (1)
China (1)
Colombia (1)
Cuba (1)
Denmark (2)
Ecuador (1)
Finland (3)
France (6)
French Polynesia (1)
Germany (4)
Iceland (1)
India (1)
Israel (1)
Italy (2)
Mexico (1)
Netherlands (5)
New Caledonia (1)
Norway (1)
Pakistan (1)
Portugal (1)
Senegal (1)
Spain (3)
Sri Lanka (1)
Switzerland (2)
United Kingdom (8)

Advanced search

Search projects and results

Results 1 - 8 of 8
Order by: Results/page:
1
Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active aging
ID: 633595
Start date: 2015-04-01, End date: 2019-03-31
The Gluco-Psychosocial Axis (GPA) concerns the interplay of factors determining glucose metabolism and insulin sensitivity and the neuroendocrine response resulting from exposure to psychosocial stress. A sub-optimal GPA influences the development of type 2 diabetes and...
Programme: H2020-EU.3.1.1.
Record Number: 193247
Last updated on: 2017-09-11
A global alliance for Zika virus control and prevention
ID: 734548
Start date: 2016-10-01, End date: 2019-09-30
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia...
Programme: H2020-EU.3.1.3.
Record Number: 207455
Last updated on: 2017-08-23
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication
ID: 633545
Start date: 2015-05-01, End date: 2017-12-31
Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leading to a dysfunctional CFTR protein. The disease affects over 70,000 patients worldwide and while many mutations are...
Programme: H2020-EU.3.1.
Record Number: 193242
Last updated on: 2017-08-22
GlucoCEST Imaging of Neoplastic Tumours
ID: 667510
Start date: 2016-01-01, End date: 2019-12-31
Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usually detected through advanced medical imaging. Early detection is very important as it increases the chances of survival and the...
Programme: H2020-EU.3.1.
Record Number: 199734
Last updated on: 2017-07-14
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen
ID: 115854
Start date: 2014-12-01, End date: 2019-11-30
The overall aim of the EBOVAC programme is to assess the safety and efficacy/effectiveness, if feasible, of a novel prime-boost prophylactic vaccine regimen against Ebola Virus Disease (EVD), which has been 100% effective in preclinical studies. This will be done via phase I...
Programme: H2020-EU.3.1.7.13.
Record Number: 209452
Last updated on: 2017-03-27
Family-based intervention to improve healthy lifestyle and prevent Type 2 Diabetes amongst South Asians with central obesity and prediabetes
ID: 643774
Start date: 2015-01-01, End date: 2019-12-31
South Asians, who represent one-quarter of the world’s population, are at high risk of type-2 diabetes (T2D). Intensive lifestyle modification (healthy diet and physical activity) is effective at preventing T2D amongst South Asians with impaired glucose tolerance, but this...
Programme: H2020-EU.3.1.
Record Number: 194100
Last updated on: 2017-01-09
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Start date: 2016-01-01, End date: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.
Record Number: 199738
Last updated on: 2016-11-29
Validation of calibrated RIP (respiratory inductive plethysmography) based biomarker for diagnosis of SDB (sleep-disordered breathing) and the identification of an accessible screening solution
ID: 683740
Start date: 2015-06-01, End date: 2015-10-31
Nox Medical has developed sleep diagnosis solutions since 2006. The company’s products are sold globally in all sleep diagnosis markets. New markets open up with simplifying medical systems using technological developments and telemedicine. Building on this, Nox Medical will...
Programme: H2020-EU.3.1.
Record Number: 197036
Last updated on: 2015-09-02
1
List retrieved on: 2017-11-18
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top